Famotidine 20 MG Oral Tablet [Zantac Reformulated Aug 2022] — RxCUI 2609246
RxNorm drug concept · Semantic branded drug
RxCUI 2609246
Semantic branded drug · SBD
● Current RxNorm concept 8 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2609246
Official nameFamotidine 20 MG Oral Tablet [Zantac Reformulated Aug 2022]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZantac Reformulated Aug 2022 20 MG Oral Tablet; Zantac 360 20 MG Oral Tablet, Reformulated Aug 2022
FDA products mapped8
Package NDCs mapped17
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Famotidine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It lowers stomach acid. It's used in the hospital for ulcers, GERD, or excess-acid conditions, especially when you can't take pills. It's typically used until you can switch to ora...
- Why am I getting famotidine through an IV?
- For adults it is generally given about every 12 hours through a vein. Your care team will set the exact dose and timing, which may be adjusted if your kidneys aren't working well.
- The common ones are headache, dizziness, constipation, and diarrhea. You may also notice brief irritation where the IV goes in. Tell your nurse about any of these.
🕸️ Concept Web — How Famotidine 20 MG Oral Tablet [Zantac Reformulate... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Famotidine 20 MG Oral Tablet [Zantac Reformulated Aug 2022]
RxCUI 2609246 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Famotidine
4278IN
-
Famotidine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zantac Reformulated Aug 2022
2607010BN
-
Zantac Reformulated Aug 2022
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Famotidine Oral Tablet
372140SCDF -
Famotidine Oral Product
1159021SCDG -
Famotidine Pill
1159022SCDG -
Famotidine Oral Tablet [Zantac Reformulated Aug 2022]
2607014SBDF -
Zantac Reformulated Aug 2022 Oral Product
2607012SBDG -
Zantac Reformulated Aug 2022 Pill
2607013SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Famotidine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Famotidine 20 MG Oral Tablet
310273SCD -
Famotidine 20 MG
315921SCDC -
Famotidine 20 MG [Zantac Reformulated Aug 2022]
2609245SBDC
-
Famotidine 20 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Famotidine 20 MG Oral Tablet
SCD · 310273 -
Famotidine 20 MG
SCDC · 315921 -
Famotidine Oral Tablet
SCDF · 372140 -
Famotidine Oral Product
SCDG · 1159021 -
Famotidine Pill
SCDG · 1159022
Brand-Name Concepts
-
Famotidine 20 MG [Zantac Reformulated Aug 2022]
SBDC · 2609245 -
Famotidine Oral Tablet [Zantac Reformulated Aug 2022]
SBDF · 2607014 -
Zantac Reformulated Aug 2022 Oral Product
SBDG · 2607012 -
Zantac Reformulated Aug 2022 Pill
SBDG · 2607013 -
Zantac Reformulated Aug 2022
BN · 2607010
📦 FDA Products & Package NDCs
8 products · 17 package NDCs
17 package NDCs map to RxCUI 2609246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 41167-0361-00 | 1 BLISTER PACK in 1 CARTON (41167-0361-0) / 8 TABLET, FILM... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-01 | 1 BLISTER PACK in 1 CARTON (41167-0361-1) / 1 TABLET, FILM... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-02 | 1 BOTTLE in 1 CARTON (41167-0361-2) / 25 TABLET, FILM COATE... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-04 | 1 BOTTLE in 1 CARTON (41167-0361-4) / 50 TABLET, FILM COATE... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-06 | 1 BOTTLE in 1 CARTON (41167-0361-6) / 90 TABLET, FILM COATE... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-08 | 1 BOTTLE in 1 CARTON (41167-0361-8) / 100 TABLET, FILM COAT... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0361-09 | 2 BOTTLE in 1 CELLO PACK (41167-0361-9) / 70 TABLET, FILM C... | Zantac 360 | Chattem, Inc. | 2021-04-12 |
| 41167-0364-00 | 1 BOTTLE in 1 CARTON (41167-0364-0) / 25 TABLET, FILM COATE... | Zantac 360 Cool Mint | Chattem, Inc. | 2022-12-01 |
| 50269-0155-01 | 6 BLISTER PACK in 1 BOX (50269-155-01) / 1 TABLET, FILM COA... | Zantac 360 1 per blister 6 blisters | JC World Bell Wholesale Co., Inc. | 2021-10-01 |
| 50269-0156-01 | 6 BLISTER PACK in 1 BOX (50269-156-01) / 2 TABLET, FILM COA... | Zantac 360 2 per blister 6 blisters | JC World Bell Wholesale Co., Inc. | 2021-10-01 |
| 66715-6458-02 | 1 BLISTER PACK in 1 CARTON (66715-6458-2) / 2 TABLET, FILM... | Zantac 360, Travel BASIX | Lil' Drug Store Products, Inc | 2022-10-11 |
| 66715-9758-02 | 1 BLISTER PACK in 1 CARTON (66715-9758-2) / 2 TABLET, FILM... | Zantac 360 | Lil' Drug Store Products, Inc | 2023-01-05 |
| 66715-9758-05 | 1 BLISTER PACK in 1 CARTON (66715-9758-5) / 5 TABLET, FILM... | Zantac 360 | Lil' Drug Store Products, Inc | 2021-09-20 |
| 67751-0214-01 | 1 BLISTER PACK in 1 CARTON (67751-214-01) / 1 TABLET, FILM... | Zantac 360 | Navajo Manufacturing Company Inc. | 2022-08-01 |
| 67751-0214-02 | 2 BLISTER PACK in 1 CARTON (67751-214-02) / 1 TABLET, FILM... | Zantac 360 | Navajo Manufacturing Company Inc. | 2022-08-01 |
| 85237-1926-01 | 1 BLISTER PACK in 1 CONTAINER (85237-1926-1) / 1 TABLET, FI... | Zantac 360 | Select Consumer Group LLC | 2025-06-04 |
| 85237-1926-02 | 2 BLISTER PACK in 1 CONTAINER (85237-1926-2) / 1 TABLET, FI... | Zantac 360 | Select Consumer Group LLC | 2025-06-04 |
Observed labelers:
Chattem, Inc. (8) ·
Lil' Drug Store Products, Inc (3) ·
JC World Bell Wholesale Co., Inc. (2) ·
Navajo Manufacturing Company Inc. (2) ·
Select Consumer Group LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.